Yanink Caro-Vega - Concepedia

Author

Yanink Caro-Vega

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán ORCID

Also Known As

Yanink Caro-Vega, Yanink N Caro-Vega, Yanink N. Caro-Vega

Publications

370

Citations

H-Index

Concepts

All Affiliations

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Vanderbilt University Instituto Evandro Chagas Fundacion Arriarán University of Chile

About

Yanink Caro-Vega is an author at Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán specializing in population health sciences, epidemiology, and marginal structural models.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	64
2	Public Health	2	2	64
3	Epidemiology	2	2	64
4	Global Health	2	2	64
5	Health Policy	1	1	48

Yanink Caro-Vega

Publications

342

Citations

H-Index

Page 1

	Year	Citations
High prevalence of late diagnosis of HIV in Mexico during the HAART era Brenda Crabtree‐Ramírez, Yanink Caro-Vega, Pablo F. Belaunzarán-Zamudio, Salud Pública de México	2012	81
Cross-Sectional Analysis of Late HAART Initiation in Latin America and the Caribbean: Late Testers and Late Presenters Brenda Crabtree‐Ramírez, Yanink Caro-Vega, Bryan E. Shepherd, PLoS ONE	2011	73
The Population Impact of Late Presentation With Advanced HIV Disease and Delayed Antiretroviral Therapy in Adults Receiving HIV Care in Latin America Pablo F. Belaunzarán-Zamudio, Yanink Caro-Vega, Bryan E. Shepherd, American Journal of Epidemiology ImmunodeficienciesPopulation Health SciencesLatin AmericaLogistic AnalysisHiv/aids Counselling	2019	48
Time to HAART Initiation after Diagnosis and Treatment of Opportunistic Infections in Patients with AIDS in Latin America Brenda Crabtree‐Ramírez, Yanink Caro-Vega, Bryan E. Shepherd, PLoS ONE	2016	32
Effects of National Adoption of Treat-All Guidelines on Pre-Antiretroviral Therapy (ART) CD4 Testing and Viral Load Monitoring After ART initiation: A Regression Discontinuity Analysis Ellen Brazier, Olga Tymejczyk, Elizabeth Zaniewski, Clinical Infectious Diseases	2021	28
Monitoring of HIV treatment in seven countries in the WHO Region of the Americas Pablo F. Belaunzarán-Zamudio, Yanink Caro-Vega, Bryan E. Shepherd, Bulletin of the World Health Organization	2015	19
Estimating the Impact of Earlier ART Initiation and Increased Testing Coverage on HIV Transmission among Men Who Have Sex with Men in Mexico using a Mathematical Model Yanink Caro-Vega, Carlos del Rı́o, Viviane D. Lima, PLoS ONE	2015	17
The impact of data quality and source data verification on epidemiologic inference: a practical application using HIV observational data Mark J Giganti, Bryan E. Shepherd, Yanink Caro-Vega, BMC Public Health	2019	17
A Comparison of Seven Cox Regression-Based Models to Account for Heterogeneity Across Multiple HIV Treatment Cohorts in Latin America and the Caribbean Mark J Giganti, Paula M. Luz, Yanink Caro-Vega, AIDS Research and Human Retroviruses Population Health SciencesLatin AmericaHazard Ratio EstimatesExtreme HeterogeneityEpidemiologic Method	2015	16
Different Baseline Characteristics and Different Outcomes of HIV-Infected Patients Receiving HAART Through Clinical Trials Compared With Routine Care in Mexico Alondra López‐Martínez, Nathan M. O ́ Brien, Yanink Caro-Vega, JAIDS Journal of Acquired Immune Deficiency Syndromes	2011	11

Page 1